Changmao Biotech (00954) subsidiary signs sale-leaseback contract for machinery and equipment for maleic anhydride production line

Zhitongcaijing · 06/30 13:25

Zhitong Finance App News, Changmao Biotech (00954) announced that on June 30, 2025, Changmao Dalian, a wholly-owned subsidiary of the company, signed a sale-leaseback agreement with the lessor (Changzhou Xinhui Financial Leasing Co., Ltd.). According to this, Changmao Dalian agreed to transfer the leased assets to the lessor at a total consideration of about RMB 50 million, while Changmao Dalian agreed to rent back the leased assets at a total rent of approximately RMB 57.531 million for a period of 48 months. After the lease term expires, and after receipt of all lease payments and other receivables under the sale-leaseback agreement, Changmao Dalian is not required to pay consideration, and the lessor will transfer ownership of the leased assets back to Changmao Dalian on a “as-is” basis.

The leased assets are machinery and equipment for Changmao's maleic anhydride production line in Dalian.